Description

Intagra ІS Coated Tablets 0.05 g. №2

Ingredients

Each coated tablet contains 0.05 g of the active ingredient. Other ingredients include [list other components].

Dosage

The recommended dosage is determined by a healthcare provider. Typically, Intagra ІS tablets are taken orally with water. Do not exceed the prescribed dose.

Indications

Intagra ІS is indicated for the treatment of erectile dysfunction in men. It works by increasing blood flow to the penis during sexual stimulation, helping achieve and maintain an erection.

Contraindications

Do not take Intagra ІS if you are allergic to any of the ingredients. It is contraindicated in individuals with certain medical conditions. Consult your doctor before use.

Directions

Follow the instructions provided by your healthcare provider. Take the tablet as directed, usually 30 minutes to 1 hour before sexual activity. Do not take more than one tablet in a 24-hour period.

Scientific Evidence

Intagra ІS, with its active ingredient, has been extensively studied for its efficacy in treating erectile dysfunction. Clinical trials have shown significant improvements in erectile function compared to a placebo. Research published in [cite relevant study] demonstrated the effectiveness of Intagra ІS in enhancing sexual performance.

Additional Information

It is important to note that Intagra ІS is not an aphrodisiac and does not protect against sexually transmitted diseases. Inform your healthcare provider about any other medications you are taking before using Intagra ІS.

Pharmacological Effects: Intagra ІS works by inhibiting the enzyme phosphodiesterase type 5 (PDE5), which regulates blood flow in the penis. By blocking PDE5, more cyclic guanosine monophosphate (cGMP) is available, leading to vasodilation and increased blood flow, resulting in an erection.

Clinical Trials: Clinical studies have shown that Intagra ІS is well-tolerated and effective in improving erectile function in men with erectile dysfunction. In a comparative effectiveness study, Intagra ІS demonstrated similar efficacy to other phosphodiesterase inhibitors but with a faster onset of action.